Rapid Therapeutic Science Lab inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0041
- Today's High:
- $0.0058
- Open Price:
- $0.0049
- 52W Low:
- $0.004
- 52W High:
- $1.75
- Prev. Close:
- $0.005
- Volume:
- 1275708
Company Statistics
- Market Cap.:
- $75074
- Book Value:
- -0.31
- Revenue TTM:
- $60
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $334
- Profit Margin:
- 0%
- Return on Assets TTM:
- -12.91%
- Return on Equity TTM:
- 0%
Company Profile
Rapid Therapeutic Science Lab inc had its IPO on under the ticker symbol RTSL.
The company operates in the Healthcare sector and Medical Devices industry. Rapid Therapeutic Science Lab inc has a staff strength of 3 employees.
Stock update
Shares of Rapid Therapeutic Science Lab inc opened at $0 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0 - $0.01, and closed at $0.01.
This is a 0% increase from the previous day's closing price.
A total volume of 1,275,708 shares were traded at the close of the day’s session.
In the last one week, shares of Rapid Therapeutic Science Lab inc have slipped by -50%.
Rapid Therapeutic Science Lab inc's Key Ratios
Rapid Therapeutic Science Lab inc has a market cap of $75074, indicating a price to book ratio of 136.6957 and a price to sales ratio of 193667.25.
In the last 12-months Rapid Therapeutic Science Lab inc’s revenue was $60 with a gross profit of $334 and an EBITDA of $-441090. The EBITDA ratio measures Rapid Therapeutic Science Lab inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Rapid Therapeutic Science Lab inc’s operating margin was 0% while its return on assets stood at -12.91% with a return of equity of 0%.
In Q2, Rapid Therapeutic Science Lab inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 96.9%.
Rapid Therapeutic Science Lab inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0.85
- PEG
Its diluted EPS in the last 12-months stands at $0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Rapid Therapeutic Science Lab inc’s profitability.
Rapid Therapeutic Science Lab inc stock is trading at a EV to sales ratio of 217996.8333 and a EV to EBITDA ratio of -27.7973. Its price to sales ratio in the trailing 12-months stood at 193667.25.
Rapid Therapeutic Science Lab inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $2.07 million
- Total Liabilities
- $4.43 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Rapid Therapeutic Science Lab inc ended 2024 with $2.07 million in total assets and $0 in total liabilities. Its intangible assets were valued at $2.07 million while shareholder equity stood at $-2739134.00.
Rapid Therapeutic Science Lab inc ended 2024 with $0 in deferred long-term liabilities, $4.43 million in other current liabilities, 8832.00 in common stock, $-10078456.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2160.00 and cash and short-term investments were $2160.00. The company’s total short-term debt was $3,398,001 while long-term debt stood at $150000.00.
Rapid Therapeutic Science Lab inc’s total current assets stands at $317882.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $82529.00 compared to accounts payable of $769957.00 and inventory worth $175047.00.
In 2024, Rapid Therapeutic Science Lab inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Rapid Therapeutic Science Lab inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $1.75
- 52-Week Low
- $0.004
- Analyst Target Price
- $
Rapid Therapeutic Science Lab inc stock is currently trading at $0.01 per share. It touched a 52-week high of $1.75 and a 52-week low of $1.75. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.04 and 200-day moving average was $0.36 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6360.5% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Rapid Therapeutic Science Lab inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.